Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.390
-0.040 (-1.65%)
At close: Jul 24, 2026, 4:00 PM EDT
2.385
-0.005 (-0.21%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $307.53 million as of July 24, 2026. Its market cap has decreased by -51.32% in one year.
Market Cap
307.53M
Enterprise Value
287.01M
1-Year Change
-51.32%
Ranking
Category
Stock Price
$2.39
ChartMarket Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $307.53M, a decrease of -75.13%. That is a compound annual growth rate of -16.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 307.53M | -53.22% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquestive Therapeutics | 467.99M |
| Tilray Brands | 457.45M |
| Kamada | 410.03M |
| Evolus | 389.20M |
| Canopy Growth | 380.44M |
| Emergent BioSolutions | 377.17M |
| Akebia Therapeutics | 325.93M |
| Alpha Teknova | 268.07M |